Company Overview and News
The deal is very small with a total value of roughly $33MM, which will lead to very little institutional attention. (20-2)
* Combimatrix Corp says approximately 1.79 million of common shares voting in meeting voted in favor of approval & adoption of all-stock merger agreement Source text for Eikon: Further company coverage: (20-0)
See the end of the post for my full portfolio breakdown and the last four weeks of trades. (81-5)
* CombiMatrix Corp - on Sept 25, co’s unit CombiMatrix Molecular Diagnostics Inc entered into marketing and laboratory services agreement with Invitae Corp and its unit (20-0)
IRVINE, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announced today it has set important dates for a special meeting of its stockholders to vote on matters related to the proposed merger with Invitae Corporation (“Invitae”). (35-0)
* CombiMatrix Corp - Merger has been unanimously approved by boards of directors of both companies (2-0)
August 22, 2017 - MMCAP International Inc. SPC has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 161,469 shares of CombiMatrix Corp. (NASDAQ:CBMX). This represents 5.5322 percent ownership of the company.
August 09, 2017 - Stonepine Capital Management, LLC has filed a SC 13G form disclosing ownership of 290,000 shares of CombiMatrix Corp. (NASDAQ:CBMX) corresponding to a(n) 9.96 ownership percentage. (0-1)
It was a big day Tuesday for genetic testing concern Invitae which rose some 8% on the day in a down market for biotech
Good Start Genetics provides pre-pregnancy screening; CombiMatrix also provides pre-pregnancy screening as well as post-pregnancy diagnostics.
SAN FRANCISCO, July 31, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced two acquisitions to establish a leading position in family health genetic information services. Invitae has entered into a definitive agreement to acquire privately held Good Start Genetics, a molecular diagnostics company focused on preimplantation and carrier screening for inherited disorders.
-- Good Start Genetics Provides Best-in-Class Carrier and NGS Preimplantation Screening to Leading IVF Centers -- -- CombiMatrix Trusted for Advanced DNA Diagnostics by Reproductive Health and Pediatric Specialists -- -- Invitae to Host Webcast for Investors on August 1 at 8 am ET / 5 am PT --
According to a new market research report "Preimplantation Genetic Testing Market by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application (Aneuploidy, Translocations), End User (Fertility Clinics, Research) - Forecast to 2022", published by MarketsandMarkets™, the Global Preimplantation Genetic Testing Market is projected to reach USD 541.
The weather is too nice to be spending cycles on the blog, so here's a quick summary of where I stand. Top 20% performers in green.
2017-10-28 - Wilton
2017-10-25 - Wilton
2017-10-10 - Wilton
2017-10-09 - Wilton
2017-08-25 - Wilton